• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The respiratory microbiota: associations with influenza symptomatology and viral shedding

tetano

Editor, Senior Moderator
Ann Epidemiol. 2019 Jul 31. pii: S1047-2797(19)30040-7. doi: 10.1016/j.annepidem.2019.07.013. [Epub ahead of print]
[h=1]The respiratory microbiota: associations with influenza symptomatology and viral shedding.[/h] Lee KH[SUP]1[/SUP], Foxman B[SUP]2[/SUP], Kuan G[SUP]3[/SUP], L?pez R[SUP]4[/SUP], Shedden K[SUP]5[/SUP], Ng S[SUP]6[/SUP], Balmaseda A[SUP]7[/SUP], Gordon A[SUP]8[/SUP].
[h=3]Author information[/h] 1 Center for Molecular and Clinical Epidemiology of Infectious Diseases, Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD. 2 Center for Molecular and Clinical Epidemiology of Infectious Diseases, Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor. 3 Centro de Salud S?crates Flores Vivas, Ministry of Health, Managua, Nicaragua; Sustainable Sciences Institute, Managua, Nicaragua. 4 National Virology Laboratory, Centro Nacional de Diagn?stico y Referencia, Ministry of Health, Managua, Nicaragua. 5 Department of Statistics, University of Michigan, Ann Arbor; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor. 6 Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor. 7 Sustainable Sciences Institute, Managua, Nicaragua; National Virology Laboratory, Centro Nacional de Diagn?stico y Referencia, Ministry of Health, Managua, Nicaragua. 8 Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor. Electronic address: gordonal@umich.edu.

[h=3]Abstract[/h] [h=4]PURPOSE:[/h] Manifestations of infection and the degree of influenza virus vary. We hypothesized that the nose/throat microbiota modifies the duration of influenza symptoms and viral shedding. Exploring these relationships may help identify additional methods for reducing influenza severity and transmission.
[h=4]METHODS:[/h] Using a household transmission study in Nicaragua, we identified secondary cases of influenza virus infection, defined as contacts with detectable virus or a greater than 4-fold change in hemagglutinin inhibition antibody titer. We characterized the nose/throat microbiota of secondary cases before infection and explored whether the duration of symptoms and shedding differed by bacterial community characteristics.
[h=4]RESULTS:[/h] Among 124 secondary cases of influenza, higher bacterial community diversity before infection was associated with longer shedding duration (Shannon acceleration factor [AF]: 1.61, 95% confidence interval [CI]: 1.24, 2.10) and earlier time to infection (Shannon AF: 0.72, 95% CI: 0.53, 0.97; Chao1 AF: 0.992, 95% CI: 0.986, 0.998). Neisseria and multiple other oligotypes were significantly associated with symptom and shedding durations and time to infection.
[h=4]CONCLUSIONS:[/h] The nose/throat microbiota before influenza virus infection was associated with influenza symptoms and shedding durations. Further studies are needed to determine if the nose/throat microbiota is a viable target for reducing influenza symptoms and transmission.
Copyright ? 2019 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Influenza; Microbiota; Signs and symptoms; Virus shedding

PMID: 31451313 DOI: 10.1016/j.annepidem.2019.07.013
 
Back
Top Bottom